1. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications
   Danilo do Rosário Pinheiro, 2014, World Journal of Gastroenterology CrossRef
2. Immunohistochemical Biomarkers in Gastric Cancer Research and Management
   Elena Lastraioli et al, 2012, International Journal of Surgical Oncology CrossRef
3. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells
   Bo Ra You et al, 2017, Oncotarget CrossRef
4. The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
   Lin-Lin Cao et al, 2017, Oncotarget CrossRef
5. Theranostic Fluorescent Probes
   Amit Sharma et al, 2024, Chemical Reviews CrossRef
6. Epigenetic roles in the malignant transformation of gastric mucosal cells
   Jun Tie et al, 2016, Cellular and Molecular Life Sciences CrossRef
7. CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis
   Yajun Cao et al, 2022, Cancers CrossRef
8. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role
   Dimitrios Schizas et al, 2020, Current Medicinal Chemistry CrossRef
9. Zinc and Zinc-Dependent Proteins in Cancer and Chemotherapeutics
   Jenna Guynn et al, 2017, Essential and Non-essential Metals CrossRef
10. Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
    Despoina Pouloudi et al, 2021, Diagnostics CrossRef
11. Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
    Jie Wang et al, 2024, Medicinal Chemistry Research CrossRef